Sana Biotechnology, Inc. (SANA) Insider Trading Disclosures
Sana Biotechnology, Inc. (SANA) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SANA
CIK: 1770121
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerAlena Shafer
Audit LocationSeattle, Washington, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-06 | 2026-10-05 | PRIMARY DOCUMENT | 0001480212-26-000010 | View SEC Doc Filr Page |
| 8-K | 2026-09-08 | 2026-09-08 | 8-K | 0001193125-26-384405 | View SEC Doc Filr Page |
| 4 | 2026-08-27 | 2026-08-26 | PRIMARY DOCUMENT | 0002115339-26-000004 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001012975-26-000773 | View SEC Doc Filr Page |
| 10-Q | 2026-08-10 | 2026-06-30 | 10-Q | 0001193125-26-342395 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | 8-K | 0001193125-26-342371 | View SEC Doc Filr Page |
| 4 | 2026-07-07 | 2026-07-06 | PRIMARY DOCUMENT | 0001480212-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | PRIMARY DOCUMENT | 0001309988-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | PRIMARY DOCUMENT | 0001645041-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | PRIMARY DOCUMENT | 0001836301-26-000014 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | PRIMARY DOCUMENT | 0001757533-26-000011 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | PRIMARY DOCUMENT | 0001376247-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | PRIMARY DOCUMENT | 0001480212-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | PRIMARY DOCUMENT | 0001612312-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | PRIMARY DOCUMENT | 0001770121-26-000003 | View SEC Doc Filr Page |
| 8-K | 2026-06-05 | 2026-06-04 | 8-K | 0001193125-26-259532 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-21 | — | SCHEDULE 13G Filing | 0001346824-26-000166 | View SEC Doc Filr Page |
| 8-K | 2026-05-15 | 2026-05-15 | 8-K | 0001193125-26-226674 | View SEC Doc Filr Page |
| S-8 | 2026-05-11 | — | S-8 | 0001193125-26-216824 | View SEC Doc Filr Page |
| 10-Q | 2026-05-11 | 2026-03-31 | 10-Q | 0001193125-26-216769 | View SEC Doc Filr Page |
| 8-K | 2026-05-11 | 2026-05-11 | 8-K | 0001193125-26-216758 | View SEC Doc Filr Page |
| ARS | 2026-04-24 | 2025-12-31 | ARS | 0001193125-26-174895 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-24 | — | DEFA14A | 0001193125-26-174886 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-24 | 2026-06-04 | DEF 14A | 0001193125-26-174883 | View SEC Doc Filr Page |
| 8-K | 2026-04-24 | 2026-04-22 | 8-K | 0001193125-26-174531 | View SEC Doc Filr Page |